In a recent meta-analysis, researchers investigated the association between vasectomy and risk of developing high-grade, advanced-stage, or fatal prostate cancer.
A recent randomized trial compared radical prostatectomy with observation on long-term mortality outcomes and adverse events among men with localized prostate cancer.
Researchers at the Cleveland Clinic have developed a new test for diagnosing prostate cancer to improve screening and treatment strategies by better identifying the grade of disease.
Two new studies compared changes in quality of life and the occurrence of adverse events associated with contemporary treatments for localized prostate cancer.
A recent study examined whether changes in screening practices has led to changes in the incidence of advanced and metastatic prostate cancer at diagnosis.
Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with opioid dependence, prostate cancer, and multiple sclerosis.
